Compare $CAPR vs $RZLT | Chartloom

Compare

$CAPR vs $RZLT

Capricor Therapeutics Inc · Rezolute Inc

CAPR

Capricor Therapeutics Inc

RZLT

Rezolute Inc

Compare $CAPR vs $RZLT

Comparing Capricor Therapeutics Inc and Rezolute Inc

CAPRCapricor Therapeutics Inc

RZLTRezolute Inc

CAPRCapricor Therapeutics Inc

Market cap

$453M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.84x

Rev growth (TTM)

-100.0%

YTD performance

-72.3%

52W performance

4.4%

FCF yield

-28.6%

RZLTRezolute Inc

Market cap

$469M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

124.9%

52W performance

-44.2%

FCF yield

-13.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CAPR

RZLT

Detailed metrics comparison

CAPR

Capricor Therapeutics Inc

RZLT

Rezolute Inc

Market Cap

CAPR$453M

RZLT$469M

Enterprise Value

CAPR$433M

RZLT$458M

Price

CAPR$7.83

RZLT$4.87

P/E Ratio

CAPRN/A

RZLTN/A

P/S Ratio

CAPR23.36x

RZLT0.00x

EV/Sales

CAPR22.42x

RZLT0.00x

EV/EBITDA

CAPR1,019.20x

RZLT0.00x

P/B Ratio

CAPR2.11x

RZLT3.85x

P/FCF Ratio

CAPRN/A

RZLTN/A

EV/FCF

CAPR-3.33x

RZLT-7.09x

PEG Ratio

CAPRN/A

RZLTN/A

Forward P/E (NTM)

CAPRN/A

RZLTN/A

Forward P/S (NTM)

CAPR6.84x

RZLTN/A

Revenue (TTM)

CAPR$0

RZLT$0

Revenue Growth (YoY)

CAPR-100.0%

RZLTN/A

Forward Rev Growth

CAPR-27.8%

RZLT2194.8%

Gross Margin (TTM)

CAPR0.0%

RZLT0.0%

Operating Margin (TTM)

CAPR0.0%

RZLT0.0%

EBITDA Margin (TTM)

CAPR0.0%

RZLT0.0%

Net Margin (TTM)

CAPR0.0%

RZLT0.0%

FCF Margin (TTM)

CAPRN/A

RZLTN/A

Net Income (TTM)

CAPR$-129M

RZLT$-78M

FCF (TTM)

CAPR$-130M

RZLT$-65M

EPS (TTM)

CAPR-$2.23

RZLT-$0.74

ROE (TTM)

CAPR-5660.0%

RZLT-6299.0%

ROA (TTM)

CAPR-4397.0%

RZLT-5794.0%

ROIC (TTM)

CAPR-5562.0%

RZLT-6299.0%

Cash

CAPR$21M

RZLT$11M

Debt

CAPR$0

RZLT$0

Net Cash/Debt

CAPR$21M

RZLT$11M

Current Ratio (TTM)

CAPR7.35x

RZLT9.68x

Quick Ratio (TTM)

CAPR7.22x

RZLT9.44x

Debt/Equity (TTM)

CAPR0.02x

RZLT0.00x

Debt/Assets (TTM)

CAPR0.0%

RZLT0.0%

Interest Coverage (TTM)

CAPRN/A

RZLTN/A

Net Debt/EBITDA (TTM)

CAPR0.00x

RZLT0.00x

Beta

CAPR0.59

RZLT0.58

52W Performance

CAPR4.4%

RZLT-44.2%

YTD Performance

CAPR-72.3%

RZLT124.9%

% from 52W High

CAPR-80.6%

RZLT-57.5%

% from 52W Low

CAPR164.5%

RZLT355.1%

Asset Turnover (TTM)

CAPR0.25x

RZLT0.00x

FCF Yield (TTM)

CAPR-28.6%

RZLT-13.8%

Earnings Yield (TTM)

CAPR-28.5%

RZLT-16.5%

Dividend Yield (TTM)

CAPRN/A

RZLTN/A

Rule of 40

CAPR-100.0

RZLT0.0

EV/GP/RG

CAPRN/A

RZLTN/A

Ticker research

View CAPR research View RZLT research

Metric	CAPR Capricor Therapeutics Inc	RZLT Rezolute Inc
Market & Valuation
Market Cap	$453M	$469M
Enterprise Value	$433M	$458M
Price	$7.83	$4.87
P/E Ratio	N/A	N/A
P/S Ratio	23.36x	0.00x
EV/Sales	22.42x	0.00x
EV/EBITDA	1,019.20x	0.00x
P/B Ratio	2.11x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.33x	-7.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.84x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	-27.8%	2194.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-129M	$-78M
FCF (TTM)	$-130M	$-65M
EPS (TTM)	-$2.23	-$0.74
ROE (TTM)	-5660.0%	-6299.0%
ROA (TTM)	-4397.0%	-5794.0%
ROIC (TTM)	-5562.0%	-6299.0%
Financial Health
Cash	$21M	$11M
Debt	$0	$0
Net Cash/Debt	$21M	$11M
Current Ratio (TTM)	7.35x	9.68x
Quick Ratio (TTM)	7.22x	9.44x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	0.58
52W Performance	4.4%	-44.2%
YTD Performance	-72.3%	124.9%
% from 52W High	-80.6%	-57.5%
% from 52W Low	164.5%	355.1%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.00x
FCF Yield (TTM)	-28.6%	-13.8%
Earnings Yield (TTM)	-28.5%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CAPR research	View RZLT research

Valuation

P/S Ratio

RZLT

0.00x

CAPR

23.36x

EV/FCF

RZLT

-7.09x

CAPR

-3.33x

Growth & revenue

Revenue Growth TTM

CAPR

-100.0%

Forward Revenue Growth

RZLT

2194.8%

CAPR

-27.8%

Profitability & performance

Gross Margin

CAPR

0.0%

RZLT

0.0%

ROE

CAPR

-5660.0%

RZLT

-6299.0%

FCF Yield %

RZLT

-13.8%

CAPR

-28.6%

52-Week Performance

CAPR

4.4%

RZLT

-44.2%

Detailed metrics comparison

CAPR

Capricor Therapeutics Inc

RZLT

Rezolute Inc

Market Cap

CAPR$453M

RZLT$469M

Enterprise Value

CAPR$433M

RZLT$458M

Price

CAPR$7.83

RZLT$4.87

P/E Ratio

CAPRN/A

RZLTN/A

P/S Ratio

CAPR23.36x

RZLT0.00x

EV/Sales

CAPR22.42x

RZLT0.00x

EV/EBITDA

CAPR1,019.20x

RZLT0.00x

P/B Ratio

CAPR2.11x

RZLT3.85x

P/FCF Ratio

CAPRN/A

RZLTN/A

EV/FCF

CAPR-3.33x

RZLT-7.09x

PEG Ratio

CAPRN/A

RZLTN/A

Forward P/E (NTM)

CAPRN/A

RZLTN/A

Forward P/S (NTM)

CAPR6.84x

RZLTN/A

Revenue (TTM)

CAPR$0

RZLT$0

Revenue Growth (YoY)

CAPR-100.0%

RZLTN/A

Forward Rev Growth

CAPR-27.8%

RZLT2194.8%

Gross Margin (TTM)

CAPR0.0%

RZLT0.0%

Operating Margin (TTM)

CAPR0.0%

RZLT0.0%

EBITDA Margin (TTM)

CAPR0.0%

RZLT0.0%

Net Margin (TTM)

CAPR0.0%

RZLT0.0%

FCF Margin (TTM)

CAPRN/A

RZLTN/A

Net Income (TTM)

CAPR$-129M

RZLT$-78M

FCF (TTM)

CAPR$-130M

RZLT$-65M

EPS (TTM)

CAPR-$2.23

RZLT-$0.74

ROE (TTM)

CAPR-5660.0%

RZLT-6299.0%

ROA (TTM)

CAPR-4397.0%

RZLT-5794.0%

ROIC (TTM)

CAPR-5562.0%

RZLT-6299.0%

Cash

CAPR$21M

RZLT$11M

Debt

CAPR$0

RZLT$0

Net Cash/Debt

CAPR$21M

RZLT$11M

Current Ratio (TTM)

CAPR7.35x

RZLT9.68x

Quick Ratio (TTM)

CAPR7.22x

RZLT9.44x

Debt/Equity (TTM)

CAPR0.02x

RZLT0.00x

Debt/Assets (TTM)

CAPR0.0%

RZLT0.0%

Interest Coverage (TTM)

CAPRN/A

RZLTN/A

Net Debt/EBITDA (TTM)

CAPR0.00x

RZLT0.00x

Beta

CAPR0.59

RZLT0.58

52W Performance

CAPR4.4%

RZLT-44.2%

YTD Performance

CAPR-72.3%

RZLT124.9%

% from 52W High

CAPR-80.6%

RZLT-57.5%

% from 52W Low

CAPR164.5%

RZLT355.1%

Asset Turnover (TTM)

CAPR0.25x

RZLT0.00x

FCF Yield (TTM)

CAPR-28.6%

RZLT-13.8%

Earnings Yield (TTM)

CAPR-28.5%

RZLT-16.5%

Dividend Yield (TTM)

CAPRN/A

RZLTN/A

Rule of 40

CAPR-100.0

RZLT0.0

EV/GP/RG

CAPRN/A

RZLTN/A

Ticker research

View CAPR research View RZLT research

Metric	CAPR Capricor Therapeutics Inc	RZLT Rezolute Inc
Market & Valuation
Market Cap	$453M	$469M
Enterprise Value	$433M	$458M
Price	$7.83	$4.87
P/E Ratio	N/A	N/A
P/S Ratio	23.36x	0.00x
EV/Sales	22.42x	0.00x
EV/EBITDA	1,019.20x	0.00x
P/B Ratio	2.11x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.33x	-7.09x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.84x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	-27.8%	2194.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-129M	$-78M
FCF (TTM)	$-130M	$-65M
EPS (TTM)	-$2.23	-$0.74
ROE (TTM)	-5660.0%	-6299.0%
ROA (TTM)	-4397.0%	-5794.0%
ROIC (TTM)	-5562.0%	-6299.0%
Financial Health
Cash	$21M	$11M
Debt	$0	$0
Net Cash/Debt	$21M	$11M
Current Ratio (TTM)	7.35x	9.68x
Quick Ratio (TTM)	7.22x	9.44x
Debt/Equity (TTM)	0.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.59	0.58
52W Performance	4.4%	-44.2%
YTD Performance	-72.3%	124.9%
% from 52W High	-80.6%	-57.5%
% from 52W Low	164.5%	355.1%
Efficiency & Yields
Asset Turnover (TTM)	0.25x	0.00x
FCF Yield (TTM)	-28.6%	-13.8%
Earnings Yield (TTM)	-28.5%	-16.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CAPR research	View RZLT research